Embolotherapy Market Share, Trends, and Analysis by 2031
Embolotherapy Market: Strategic Insights
Embolotherapy Market
-
CAGR (2023 - 2031)8.3% -
Market Size 2023
US$ 3.88 Billion -
Market Size 2031
US$ 7.37 Billion
Market Dynamics
GROWTH DRIVERS
- Rising Patient Preference for Minimally Invasive Procedures to Favor Market
FUTURE TRENDS
- Growing Applications of Embolotherapy
OPPORTUNITIES
- Increasing Number Of Research And Development Activities
Key Players
- Abbott Laboratories
- Boston Scientific Corporation
- Cook Medical LLC
- Johnson Johnson Consumer Inc
- Medtronic
- Acandis GmbH
- Terumo Corporation
- Balt USA LLC
- Stryker Corporation
- Guerbet LLC
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product - Embolic Agent and Support Device
Disease Indication - Cancer
- Peripheral Vascular Disease
- Neurological Disease
- Urological & Nephrological Disorder
- Gastrointestinal Disorder
Procedure - Transcatheter Arterial Embolization
- Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
- Transarterial Chemoembolization
End User - Hospital & Clinic
- Ambulatory Surgery Center
- Other End User
Get Free Sample For